Amendment date: Jan 09 2015Development, Licensing and Marketing Agreement • November 21st, 2021 • New York
Contract Type FiledNovember 21st, 2021 JurisdictionAdamas Pharmaceuticals has received a $25 million milestone payment from Forest Laboratories related to the development of MDX-8704.